Galenica Ltd. - Storyhub - Medienmitteilungen und News

Consultation process at Bichsel completed

Thu, 12 Mar 2026 07:25:03 +0100

Bichsel decides to close its pharmaceutical manufacturing operations after the completion of the consultation process.

Galenica achieves strong annual result and increases mid-term guidance

Tue, 10 Mar 2026 06:40:07 +0100

Galenica increases sales in 2025 by 5.5% to CHF 4,135.6 million – all business areas contribute to growth.Adjusted¹ EBIT increases by 11.3% to CHF 234.8 million.

Galenica focuses Bichsel’s business on home care services

Tue, 24 Feb 2026 06:40:06 +0100

Bichsel intends to discontinue pharmaceutical production by the end of 2026 at the latest for economic reasons. This affects up to 170 jobs.

Galenica continues to grow: sales increase to over CHF 4 billion

Thu, 22 Jan 2026 06:40:06 +0100

Sales up by 5.5% to CHF 4,135.

700 medicines are missing: How supply works despite shortages

Wed, 14 Jan 2026 00:00:00 +0100

What to do if an important medication is missing? Supply bottlenecks have long been part of everyday life in Swiss pharmacies. How Galenica is helping to secure supply in Switzerland.

Galenica further expands online offering and acquires majority stake in Puravita

Tue, 16 Dec 2025 13:55:03 +0100

Galenica increases its investment in Puravita to 80% and further expands its digital presence.

Hybrid healthcare services – a key element of tomorrow’s healthcare

Tue, 18 Nov 2025 00:00:00 +0100

What will healthcare look like in the future? This question is of concern not only to the Federal Council as part of its “Health2030” strategy, but also to universities, health insurers – and us as the leading network in the Swiss healthcare market.

Vaccinations in the pharmacy: A look behind the scenes

Tue, 11 Nov 2025 11:23:12 +0100

Vaccinations expand the duties of pharmacy staff and brings tangible benefits for the population and healthcare system – as a visit to the Amavita pharmacy in Storchengässchen in Bern shows.

Galenica successfully places a bond of over CHF 250 million

Mon, 10 Nov 2025 17:55:04 +0100

Today, Galenica successfully placed a fixed rate bond of over CHF 250 million. The bond has a term of 7 years and an annual coupon of 1.08%.

Galenica remains on growth track

Thu, 23 Oct 2025 06:40:05 +0200

Galenica Group sales grew 4.7% to CHF 2,999.7 million in the third quarter of 2025.Sales growth is driven by prescription drugs and dietary supplements.

Galenica strengthens basic care with new pharmacy concept

Tue, 21 Oct 2025 07:55:04 +0200

Pharmacies play a key role in healthcare.

HomeCare Bichsel and Lifestage Solutions: Working together for unique home care services

Fri, 17 Oct 2025 00:00:00 +0200

Galenica offers a unique range of services for retirement and nursing homes and home care organisations, hospitals and medical practices throughout Switzerland. These include the fully automated ordering and billing of consumables and care products via Lifestage Solutions as well as Bichsel’s specialised home care services. Our goal as a network: Significantly relieve the burden on nursing staff through digital solutions and specialist expertise.

Launch of Galenica Diagnostics: Acquisition of Labor Team completed

Wed, 10 Sep 2025 06:45:03 +0200

Labor Team will become part of the Galenica network once the acquisition is complete.

40 years of Spagyros: tradition meets modernity

Thu, 04 Sep 2025 07:49:23 +0200

Tradition or innovation? For the last 40 years, the answer at Spagyros has been: both. Ancient healing knowledge and cutting-edge research go hand in hand here. CEO Michael Severus explains how this balance is struck.

Galenica demonstrates pleasing growth and improves EBIT guidance

Thu, 07 Aug 2025 06:45:06 +0200

Galenica Group sales grew by 5.0% to CHF 1,995.4 million in the first half of 2025.Adjusted EBIT¹ increased by 10.9% to CHF 109.

New internal appointment of General Counsel and Secretary General

Tue, 05 Aug 2025 14:12:27 +0200

Barbara Wälchli, General Counsel and Secretary General, has decided to leave Galenica at the end of 2025. With Cécile Matter as the new General Counsel and Jürg Pauli as the future Secretary General of the Board of Directors, two experienced executives from within the company are taking over the reins.

Galenica and the invisible work behind safe medications

Thu, 24 Jul 2025 00:00:00 +0200

What does it take to ensure that only safe and effective medications reach people in Switzerland? Galenica ensures that quality standards are met – from the place of manufacture all the way to the pharmacy or hospital. In this story, you’ll find out exactly how this works and what it has to do with underfloor heating.

Yves Platel is the new President of the Association of Pharmacists of the Canton of Zurich

Fri, 04 Jul 2025 09:53:57 +0200

A pharmacist from the Galenica network assumes responsibility at association level: Yves Platel, Co-Managing Director of the Amavita pharmacy at Zurich Railway Station, was elected President of the Association of Pharmacists of Zurich (AKVZ) on 19 June 2025.

Galenica to enter the diagnostics business by acquiring Labor Team

Wed, 02 Jul 2025 06:45:06 +0200

By acquiring the Labor Team Group, Galenica is adding a leading Swiss diagnostic service provider to its healthcare network.

Committed together – how we support social projects

Mon, 30 Jun 2025 08:15:19 +0200

Twice a year, our employees have the opportunity to cast their vote and determine the proportion of donations for social projects on the crowddonating platform “there for you”. The first round of voting in 2025 was recently completed. With our support, one of the projects directly reached the donation target.

Personnel change in the position of General Counsel

Thu, 26 Jun 2025 00:00:00 +0200

Barbara Wälchli, General Counsel and Secretary General of Galenica, will leave the company at the end of 2025. She is moving to Swisscom as General Counsel.

Christina Ruob appointed as Professor of Practice at ETH Zurich

Wed, 04 Jun 2025 00:00:00 +0200

ETH Zurich recognises Christina Ruob’s outstanding performance in practice and will award her the title of “Professor of Practice”. This prestigious appointment underscores her important role in the teaching of pharmacy.

Between conveyor belts and barcode scanners: a self-experiment in the logistics centre

Wed, 28 May 2025 00:00:00 +0200

What happens when an office worker dives into the world of logistics? A communications employee put it to the test and spent an evening in the Galexis logistics centre, surrounded by buzzing forklifts and countless blue boxes.

Galenica continues sales growth

Thu, 22 May 2025 06:45:06 +0200

Sales growth of 4.7% to CHF 1,314.2 million Strong growth in all key business areas Guidance for 2025 confirmed – sales growth of 3-5% and EBIT¹ growth of 4-6% expected

A temporary site that symbolises new forms of work

Thu, 15 May 2025 08:48:02 +0200

Galenica’s temporary site, which we call the “Swing Space”, combines flexible working and sustainability with forward-thinking collaboration models.

Megatrends: Thinking about tomorrow today

Wed, 14 May 2025 09:14:29 +0200

A strong healthcare system requires cooperation. Together, we can find answers to the megatrends.

More responsibility for pharmacies in providing care from 2027

Wed, 14 May 2025 00:00:00 +0200

The revision of the Health Insurance Act (HIA) strengthens the position of pharmacies as important players in the healthcare system. The development of the around 380 pharmacies in the Galenica network shows how investments in training, infrastructure and digital solutions are already paying off today.

«Sustainability cannot be achieved on your own»

Tue, 13 May 2025 00:00:00 +0200

Marc Werner, CEO, explains in an interview how Galenica's network philosophy strengthens its sustainable behaviour.

The pharmacy is becoming the first point of contact for health issues

Fri, 09 May 2025 00:00:00 +0200

With long waiting times for GPs and overcrowded emergency departments, many people are looking for faster access to medical assistance. Pharmacies are playing an increasingly important role in this. Galenica shows how pharmacies can meaningfully relieve strain on our healthcare system.

Galenica Annual General Meeting approves all motions and elects new member of the Board of Directors

Thu, 10 Apr 2025 18:12:23 +0200

All motions of the Board of Directors approved with broad consensusNadine Balkanyi-Nordmann elected as a new member of the Board of DirectorsDividend of CHF 2.

Galenica continues to grow in 2024

Tue, 11 Mar 2025 06:45:00 +0100

With sales up 4.7% in the 2024 financial year, the Galenica Group grew strongly and generated consolidated net sales of CHF 3,921.1 million.

Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors

Thu, 23 Jan 2025 07:00:05 +0100

Nadine Balkanyi-Nordmann, an experienced legal, compliance and governance expert, will be recommended for election as a member of the Board of Directors at the next

Galenica reports strong sales growth once again

Thu, 23 Jan 2025 06:45:20 +0100

Galenica Group sales once again performed very positively in 2024, with growth of 4.7% to CHF 3,922 million.

Galenica mourns the loss of Dr. Andreas Walde

Wed, 18 Dec 2024 00:00:00 +0100

It is with great sadness that we announce the passing of Dr. iur. Andreas Walde, a long-standing member of the Board of Directors of Galenica Ltd., following a prolonged and severe illness.

Michael Severus assumes leadership of Padma Ltd.

Tue, 10 Dec 2024 00:00:00 +0100

Michael Severus will become CEO of Padma Ltd. from January 2025. Padma Ltd. is a manufacturer of Tibetan herbal remedies.

Patrick Rindlisbacher and Martin Recknagel now jointly manage Medifilm

Fri, 29 Nov 2024 00:00:00 +0100

The specialist in drug blister packaging within the Galenica network has a new management model. Patrick Rindlisbacher, the current head of Medifilm, has been co-managing Medifilm with Martin Recknagel since 1 November 2024.

Developing new approaches to basic care – across professions and together with patients

Thu, 28 Nov 2024 00:00:00 +0100

As part of the second edition of the “Healthcare Professionals Initiative”, around 130 professionals from the healthcare sector and 11 patients worked together to develop practical solutions for specific practical cases.

Expansion of the partnership between Cooper Consumer Health and Verfora Ltd.

Tue, 12 Nov 2024 00:00:00 +0100

Cooper Consumer Health and Verfora Ltd. are intensifying their collaboration. For several years, Verfora Ltd. has been distributing the Excilor and Oenobiol brands for Cooper Consumer Health. From 1 January 2025, former Viatris OTC products will be added to the portfolio.

Galenica increases sales growth in the third quarter

Thu, 24 Oct 2024 06:45:15 +0200

Following solid sales growth of 2.6% in the first half of 2024, Galenica grew more strongly again in the third quarter and generated net sales of CHF 2,864.

Galenica supports “Health first. An exhibition with side effects” at the Stapferhaus

Wed, 23 Oct 2024 00:00:00 +0200

On 10 November 2024, the Stapferhaus in Lenzburg will open “Health first. An exhibition with side effects”. The new exhibition takes visitors on an interactive tour and asks key questions about health: How do we deal with illness? How healthy is healthy enough? Who is responsible for health, who pays the price, and what visions are there for the healthcare system of the future?

Lukas Ackermann is Top CIO of the Year

Thu, 26 Sep 2024 00:00:00 +0200

Lukas Ackermann, Head of IT & Digital Business at Galenica, has been honoured with the Confare Top CIO Award 2024. This prestigious award is presented annually by EY Switzerland in collaboration with the CIO platform Confare.

New work, new space!

Wed, 14 Aug 2024 00:00:00 +0200

What happens when change becomes visible and tangible – and at a temporary workspace no less? Read on to find out.

Expansion of the Executive Committee and handover of the position of CFO

Tue, 06 Aug 2024 07:00:13 +0200

Galenica is aligning its pharmacy business to an even greater focus on customers.

Galenica achieves solid growth in a challenging market environment

Tue, 06 Aug 2024 06:45:17 +0200

Galenica Group sales grew by 2.6% to CHF 1,900.0 million in the first half of 2024.

Galenica increases shareholding in Redcare Pharmacy to 10%

Mon, 22 Jul 2024 18:11:12 +0200

Today, Galenica notified the Dutch Authority for the Financial Markets (AFM) of its 10% stake in Redcare Pharmacy N.V.

Galenica on track with sales growth

Thu, 23 May 2024 06:45:15 +0200

The Galenica Group made a good start to the new year with sales growth of 4.8% to CHF 1,255.5 million in the first four months of 2024.

Sustainable and future-oriented: Galenica’s logistics companies take responsibility

Tue, 23 Apr 2024 00:00:00 +0200

From solar panels, to habitats for wild bees and electric vehicles, the sustainability initiatives of Galexis, Alloga and Unione Farmaceutica Distribuzione (UFD) are creative and effective.

Galenica successfully places a bond of over CHF 100 million

Tue, 16 Apr 2024 18:05:32 +0200

Today, Galenica successfully placed a fixed rate bond of over CHF 100 million.

7th Annual General Meeting: Shareholders approve all proposals

Wed, 10 Apr 2024 17:29:42 +0200

The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern.

HCI Solutions unveils new brand image

Mon, 25 Mar 2024 00:00:00 +0100

In March, HCI Solutions underwent a rebranding that not only introduces a fresh new look, but also emphasises the company's transition towards developing data-driven healthcare solutions.

Galenica continues to grow in the 2023 financial year

Tue, 12 Mar 2024 06:45:21 +0100

The Galenica Group achieved strong growth with an increase in sales of 4.4% in the 2023 financial year and generated consolidated net sales of CHF 3,746.0 million.

“Living with Parkinson’s disease” – a care management offer for those affected and their relatives

Fri, 01 Mar 2024 00:00:00 +0100

With the new Home Care Coordination Service, which was created in 2023, we support patients in organising and coordinating their treatment and in procuring products and medical aids. This not only makes life easier for those affected, but also relieves the burden on their relatives. The pilot project “Leben mit Parkinson” (Living with Parkinson’s), an initiative of the Home Care Coordination Service, shows that the offer is met with great interest and appreciation.

Galenica again achieves strong sales growth

Thu, 18 Jan 2024 06:45:13 +0100

Galenica Group sales performed well in 2023, growing by 4.4% to CHF 3,746.0 million. As expected, sales growth of 3.

The Amavita Bahnhof Apotheke in Zurich shines in new splendour

Fri, 03 Nov 2023 00:00:00 +0100

The time has finally come: After a three-year renovation phase, the team from the Amavita Bahnhof Apotheke in Zurich main station is able to welcome its customers back to their original location in renovated and redesigned premises. As part of the renovation work on the south wing of Zurich main station, the pharmacy had to move to the temporary site in Wannerhalle in March 2020.

Galenica invests in salary adjustments and attractiveness as an employer

Tue, 08 Nov 2022 00:00:00 +0100

In 2023, Galenica will grant all its employees a fixed cost-of-living adjustment. It is investing over CHF 14 million, thus increasing the payroll for its employees by a total of 3.1 per cent. Additional measures are being implemented for pharmacy staff to increase its attractiveness as an employer.

Galenica hands over Careproduct to new owners

Wed, 21 Sep 2022 00:00:00 +0200

Omni-channel – i.e. the link between online and offline – is a key element of the Galenica strategy. Contrary to earlier expectations, the Careproduct product range cannot be optimally integrated at Galenica. For this reason, Galenica is selling its subsidiary Careproduct to SAB Management Holding Ltd. and its owner Bruno Sauter, effective 20 September 2022.

Galexis opens its modernised logistics site in French-speaking Switzerland

Thu, 08 Sep 2022 00:00:00 +0200

After around 40 months of construction, Galexis opens the modernised distribution centre in Lausanne-Ecublens.

Change of leadership at HCI Solutions

Wed, 01 Jun 2022 00:00:00 +0200

Markus Sager is the new CEO of the business unit HCI Solutions AG. He succeeds Lukas Ackermann, who will in future concentrate fully on his duties as Head of the IT & Digital Services Service Unit of the Galenica group.

Ukraine aid: Galenica carries out humanitarian transports and donates CHF 116,000 to Swiss Solidarity

Tue, 15 Mar 2022 00:00:00 +0100

Galenica is doubling the amount donated to Swiss Solidarity by its employees over the past two weeks. At the same time, two humanitarian transports with medicines and medical supplies under the leadership of Galexis reached their destination in Ukraine.

First humanitarian transport from Galenica arrives in Ukraine

Tue, 08 Mar 2022 00:00:00 +0100

A lorry with 27 pallets full of medicines and medical articles, which left the Galexis distribution centre in Niederbipp last Saturday, arrived in Lviv, Ukraine, yesterday.

Help for Ukraine

Fri, 04 Mar 2022 00:00:00 +0100

The employees of the Galenica Group are following the war in Ukraine with horror and bewilderment. To help the people on the ground, Galenica has launched two immediate initiatives.